Talphera, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TLPH Nasdaq 2830 talphera.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Talphera, Inc.

Talphera Inc (TLPH) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions and FDA ... - May 15th, 2025 1:16 am
Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update - May 14th, 2025 2:05 pm
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025 - May 7th, 2025 2:05 pm
Talphera Inc (TLPH) Q4 2024 Earnings Call Highlights: Strategic Moves and Financial Insights - Apr 1st, 2025 1:03 am
Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - Mar 31st, 2025 2:05 pm
Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million - Mar 31st, 2025 6:30 am
Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025 - Mar 26th, 2025 2:38 pm
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study - Jan 14th, 2025 6:30 am
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors - Nov 24th, 2024 5:27 pm
Talphera Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.085 loss in 3Q 2023) - Nov 16th, 2024 6:14 am
Talphera Inc (TLPH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges - Nov 14th, 2024 12:14 am
Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Nov 13th, 2024 2:05 pm
Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 - Nov 6th, 2024 2:05 pm
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - Oct 8th, 2024 2:54 pm
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Sep 5th, 2024 2:15 pm
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit - Aug 19th, 2024 6:30 am
Talphera First Half 2024 Earnings: US$0.31 loss per share (vs US$0.40 loss in 1H 2023) - Aug 17th, 2024 8:44 am
Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update - Aug 14th, 2024 2:01 pm